| Literature DB >> 30395525 |
Stuart Silverman1,2,3, Eli Kupperman4, Susan Bukata3.
Abstract
Atypical femoral fracture is a rare but serious complication of long-term bisphosphonate therapy. Although the benefit of preventing osteoporotic fractures greatly outweighs the risk of atypical fracture in bisphosphonate users, concern about atypical fracture risk has led to a decrease in bisphosphonate use. What are the risks, and how do we treat atypical femoral fracture?Entities:
Mesh:
Substances:
Year: 2018 PMID: 30395525 DOI: 10.3949/ccjm.85a.17119
Source DB: PubMed Journal: Cleve Clin J Med ISSN: 0891-1150 Impact factor: 2.321